Fluorescent Metal Complex Labeling for Membrane Protein Internalization Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting membrane protein internalization, particularly for GPCRs, are limited by the unstable nature of arrestin-GPCR binding and require improvements for sensitivity and high-throughput applications, especially in identifying compounds that induce internalization.
Innovation Solution
A method involving labeling proteins with fluorescent metal complexes, such as lanthanide or ruthenium compounds, and using modulating agents like FRET acceptors or reducing agents to detect internalization by measuring luminescence changes, which is sensitive and suitable for high-throughput analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If arrestin-GPCR binding is used as a marker for GPCR activation, then the detection of internalization can be achieved, but the unstable nature of this binding limits sensitivity and reliability
Solution Approach 1:
The patent introduces a fluorescent metal complex as an intermediary label that binds to the GPCR with high affinity and stability. This complex serves as a mediator between the GPCR and the detection system, providing a stable signal that does not depend on the unstable arrestin-GPCR interaction. The fluorescent metal complex remains bound to the GPCR throughout the internalization process, enabling reliable detection even when only 10-40% of receptors are internalized.
Solution Approach 2:
The patent utilizes changes in luminescence parameters (intensity, lifetime) of the fluorescent metal complex as detection signals. By monitoring these parameter changes rather than relying on the stability of protein-protein binding, the system achieves high sensitivity in detecting internalization events. The luminescence parameters provide a quantifiable measure that reflects the internalization state without being affected by the instability of arrestin-GPCR binding.
2Productivity
If conventional methods are used to detect GPCR internalization, then the basic detection capability is maintained, but high-throughput application and compound identification are limited
Solution Approach 1:
The patent replaces complex mechanical or biochemical detection systems with a simpler luminescence-based measurement system. By using fluorescent metal complexes that emit light upon excitation, the detection method can be automated and scaled for high-throughput applications. The luminescence signal can be read using standard plate readers or fluorescence microscopes, enabling efficient screening of multiple compounds without requiring complex instrumentation.
Solution Approach 2:
The fluorescent metal complex serves multiple functions simultaneously: it labels the GPCR, provides a stable binding signal, and generates a detectable luminescence output. This multi-functionality simplifies the overall detection system by eliminating the need for separate labeling and detection components, thereby enabling high-throughput screening while reducing system complexity.
3Measurement precision
If only stable binding markers are used, then measurement precision is improved, but the ability to detect early internalization events (10-40% internalization) is reduced
Solution Approach 1:
The fluorescent metal complex acts as a persistent intermediary that remains bound to the GPCR throughout the internalization process. Unlike arrestin binding that occurs only at later stages, the fluorescent metal complex is bound from the beginning and continues to signal even when only 10-40% of receptors are internalized. This persistent binding enables detection of early internalization events with high precision.
Solution Approach 2:
The fluorescent metal complex is bound to the GPCR before internalization occurs, establishing a stable signal in advance. This preliminary binding ensures that the detection system is already in place and ready to detect internalization events as they occur, rather than requiring the formation of stable complexes after internalization has happened. This allows sensitive detection of early internalization stages.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for the detection of protein internalization with enhanced sensitivity, capable of observing variations even when only 10-40% of receptors are internalized, and is applicable for identifying compounds that induce internalization, such as agonists and antagonists.
Implementation Method 1
measuring a variation in the luminescence of said fluorescent metal complex when it is internalized
Implementation Method 2
a fluorescent or nonfluorescent FRET acceptor compound compatible with said fluorescent metal complex
Data Source
AI summary
The instant invention provides for methods for detecting the internalization of a transmembrane protein of interest expressed at the surface of a cell. More specifically, the methods involve (a) labelling the protein of interest with a fluorescent metal complex, the lifetime of which is greater than 0.1 ms, (b) adding to the reaction medium a composition capable of causing the internalization of the protein of interest, (c) adding to the reaction medium (1) a modulating agent which is a fluorescent FRET acceptor compound compatible with the fluorescent metal complex, the final concentration of which in the reaction medium is greater than 10−7M; or (2) a reducing agent, the redox potential of which is less than +0.1 V and preferably between 0.25 and 0.75 V; or (3) an agent which binds specifically, by non-covalent bonding, with the fluorescent metal complex; (d) adding a metal ion which competes with the rare earth so as to form a non-fluorescent metal complex; (d) measuring the luminescence emitted by the reaction medium at the emission wavelength of the fluorescent metal complex and/or at the emission wavelength of the modulating compound when the compound is a fluorescent acceptor compound; and (e) comparing the signal measured in step d) with a reference signal measured on cells having been subjected only to steps a) and c).